As these medications come in injectable form, they are administered as a once weekly injection under the skin (subcutaneously) in the belly, outer thighs, upper buttocks, or the back of the arms
GLP-1 drugs: We provide a framework for building a long-range forecast to help employers understand how trends may change over time
If side effects become severe, persistent, or make it difficult to eat or drink, its important to speak with your healthcare provider rather than trying to push through them
For those managing their GLP-1 therapy comprehensively, knowing whether tirzepatide causes fatigue , understanding proper tirzepatide storage in the fridge and refrigeration requirements , and following tirzepatide before and after results from other patients can help set realistic expectations across all dimensions of the treatment experience
This finding positions GLP-1 medications as essential tools alongside traditional CVD therapies
Potential Downsides and Unknowns Long-term safety : Retatrutide is still in trials, so long-term LDL and cardiovascular outcomes arent confirmed